Dr. Rini on Standards of Care for Advanced RCC

onclivetv has 407 videos Subscribe Here

Description: Visit for more videos.

Brian I. Rini, MD, a staff member in the Department of Solid Tumor Oncology at the Taussig Cancer Institute at Cleveland Clinic in Ohio, discusses the lack of a current standard of care for advanced renal cell carcinoma. He describes how trials, such as the AXIS 1032 phase III trial comparing axitinib to sorafenib in the second-line setting for metastatic renal cell carcinoma (mRCC), can help improve treatment options for the disease.
Shared By : onclivetv
Posted on : 07/14/11
Added : 8 years ago
Category :